Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

11.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.5K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.2K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

4.6K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
4.6K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

3.7K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.7K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Activated Macrophages Promote TNF-α-Associated Tumor Cell Necroptosis in Pituitary Apoplexy Through the PIEZO1-NFATC2/REL Axis.

International journal of molecular sciences·2026
Same author

Research on the Formability of 2A12 Aluminum Alloy Sheet During High-Speed Hot Gas Bulging.

Materials (Basel, Switzerland)·2026
Same author

Beyond Epilepsy Control: Repurposing Antiepileptic Drugs in Central Nervous System Tumor Therapy.

Cells·2026
Same author

Specific depletion of TIGIT<sup>high</sup> CD226<sup>-</sup> clonally expanded intratumoral Tregs defines safe and effective TIGIT targeting.

Journal for immunotherapy of cancer·2026
Same author

Greater efficiency of the double-bending method compared with conventional endoscopic submucosal dissection for the treatment of submucosal tumors of the gastric fundus.

Surgical endoscopy·2026
Same author

Tailored ZnCu Conductive MOF as a Floating-Gate in Carbon Nanotube Network FET NH<sub>3</sub> Sensors.

ACS sensors·2025
Same journal

A Multi-Modal Framework for Phage-Host Interaction Prediction Using Multi-View Contrastive Learning.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

Decoding Gene-Disease Associations with Computational Methods: A Survey.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

A Competitive Coevolution-based Cancer Driver Pathway Identification Algorithm for Maximizing Coverage, Mutual Exclusivity, and Subnet Importance.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

Prediction of GO Terms Based on Partitioning PPI Networks into Highly Connected Components.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

Modeling and Tracking of Heterogeneous Cell Populations via Open Multi-Agent Systems.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

Parameter Efficient Deep Learning Models for Multi-Target Binding Affinity and hERG Cardiotoxicity Prediction.

IEEE transactions on computational biology and bioinformatics·2026
See all related articles

Related Experiment Video

Updated: Jan 9, 2026

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K

MMFF-DDI: A Multi-Modal Fusion Framework for Drug-Drug Interaction Event Prediction With Contrastive Learning.

Jian Zhong, Haochen Zhao, Guihua Duan

    IEEE Transactions on Computational Biology and Bioinformatics
    |December 1, 2025
    PubMed
    Summary
    This summary is machine-generated.

    Predicting drug-drug interaction events (DDIEs) is crucial for safe combination therapies. Our MMFF-DDI framework uses multi-modal learning to improve prediction accuracy for both existing and new drugs.

    More Related Videos

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.5K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    19.4K

    Related Experiment Videos

    Last Updated: Jan 9, 2026

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    12.5K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.5K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    19.4K

    Area of Science:

    • Pharmacology
    • Computational Chemistry
    • Artificial Intelligence in Drug Discovery

    Background:

    • Accurate prediction of drug-drug interaction events (DDIEs) is essential for optimizing combination therapies and enhancing drug safety.
    • Existing prediction methods often struggle to integrate local chemical substructures and 3D geometric features due to reliance on limited representations.

    Purpose of the Study:

    • To develop an advanced multi-modal fusion framework, MMFF-DDI, for improved drug-drug interaction event (DDIE) prediction.
    • To overcome the limitations of current methods by jointly capturing diverse molecular features.

    Main Methods:

    • MMFF-DDI employs a multi-modal approach, extracting drug representations from Morgan fingerprints, canonical SMILES, and 3D molecular graphs.
    • Utilizes an attention-augmented autoencoder, MolFormer encoder, and Equivariant Graph Neural Network (EGNN) for feature extraction.
    • Incorporates a contrastive multi-modal integration submodule for alignment-based learning, enhancing cross-modal consistency and feature fusion.

    Main Results:

    • MMFF-DDI significantly outperformed existing methods in predicting DDIEs for existing drugs, showing improvements of 7.87% in Macro-F1 and 7.99% in Macro-precision.
    • For novel drug DDIE prediction, MMFF-DDI surpassed competitive methods with 8.06% and 12.79% increases in Macro-F1 and Macro-precision, respectively.
    • Visualization and case studies confirmed the framework's practical applicability and superior predictive performance.

    Conclusions:

    • MMFF-DDI offers a robust and effective solution for predicting drug-drug interaction events by leveraging multi-modal data and contrastive learning.
    • The proposed framework enhances the accuracy and reliability of DDIE prediction, contributing to safer and more effective pharmacotherapy.
    • The source code is publicly available, facilitating further research and development in this critical area.